FR2366313B1 - - Google Patents

Info

Publication number
FR2366313B1
FR2366313B1 FR7729740A FR7729740A FR2366313B1 FR 2366313 B1 FR2366313 B1 FR 2366313B1 FR 7729740 A FR7729740 A FR 7729740A FR 7729740 A FR7729740 A FR 7729740A FR 2366313 B1 FR2366313 B1 FR 2366313B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7729740A
Other languages
French (fr)
Other versions
FR2366313A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2645105A external-priority patent/DE2645105C2/de
Priority claimed from DE19772742982 external-priority patent/DE2742982C2/de
Application filed by Schering AG filed Critical Schering AG
Publication of FR2366313A1 publication Critical patent/FR2366313A1/fr
Application granted granted Critical
Publication of FR2366313B1 publication Critical patent/FR2366313B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7729740A 1976-10-04 1977-10-04 Derives de la chloro-9 prednisolone et medicaments qui en contiennent Granted FR2366313A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2645105A DE2645105C2 (de) 1976-10-04 1976-10-04 Derivate des 9-Chlorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
DE19772742982 DE2742982C2 (de) 1977-09-21 1977-09-21 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat

Publications (2)

Publication Number Publication Date
FR2366313A1 FR2366313A1 (fr) 1978-04-28
FR2366313B1 true FR2366313B1 (de) 1980-02-01

Family

ID=25770978

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7729740A Granted FR2366313A1 (fr) 1976-10-04 1977-10-04 Derives de la chloro-9 prednisolone et medicaments qui en contiennent

Country Status (21)

Country Link
JP (1) JPS5359654A (de)
AT (1) AT358202B (de)
CH (4) CH630098A5 (de)
DK (1) DK438277A (de)
ES (1) ES462887A1 (de)
FI (1) FI58645C (de)
FR (1) FR2366313A1 (de)
GB (1) GB1594852A (de)
GR (1) GR73041B (de)
HU (1) HU179593B (de)
IE (1) IE45877B1 (de)
IL (1) IL53030A (de)
IT (1) IT1113623B (de)
LU (1) LU78223A1 (de)
NL (1) NL7710869A (de)
NO (1) NO148597C (de)
NZ (1) NZ185295A (de)
PL (1) PL110392B1 (de)
PT (1) PT67109B (de)
SE (1) SE431655B (de)
SU (2) SU743581A3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853785A1 (de) * 1978-12-11 1980-06-19 Schering Ag Neue prednison-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung
JPH0374245A (ja) * 1989-08-12 1991-03-28 Mk Seiko Co Ltd 洗車機
BR112012024289A2 (pt) 2010-03-26 2017-07-18 Galderma Res & Dev "método para fornecer um tratamento seguro e efetivo do eritema e composição de gel tópica"
AU2012324543B2 (en) 2011-10-19 2017-08-10 Galderma S.A. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
CN106632561A (zh) * 2016-12-16 2017-05-10 广州仁恒医药科技股份有限公司 一种二氟泼尼酯的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH429716A (de) * 1961-06-24 1967-02-15 Vismara Francesco Spa Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden
DE2055221A1 (en) * 1970-11-10 1972-05-18 Laboratorio Chimico Farmaceutico Dr. P. Blasina S.R.L., Mailand (Italien) 17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride

Also Published As

Publication number Publication date
IL53030A (en) 1982-11-30
SE7711039L (sv) 1978-04-05
HU179593B (en) 1982-11-29
ATA703577A (de) 1980-01-15
CH630098A5 (en) 1982-05-28
PT67109A (de) 1977-11-01
NZ185295A (en) 1980-04-28
SU751327A3 (ru) 1980-07-23
NO148597B (no) 1983-08-01
LU78223A1 (de) 1978-02-01
SU743581A3 (ru) 1980-06-25
ES462887A1 (es) 1978-12-16
JPS5359654A (en) 1978-05-29
IT1113623B (it) 1986-01-20
IE45877B1 (en) 1982-12-15
AT358202B (de) 1980-08-25
FI58645B (fi) 1980-11-28
NO148597C (no) 1983-11-09
SE431655B (sv) 1984-02-20
CH631997A5 (en) 1982-09-15
DK438277A (da) 1978-04-05
NO773362L (no) 1978-04-05
IL53030A0 (en) 1977-11-30
GB1594852A (en) 1981-08-05
PL110392B1 (en) 1980-07-31
GR73041B (de) 1984-01-26
FI772922A (fi) 1978-04-05
CH632772A5 (en) 1982-10-29
PT67109B (de) 1979-03-14
PL201161A1 (pl) 1979-01-29
NL7710869A (nl) 1978-04-06
FI58645C (fi) 1981-03-10
CH632278A5 (en) 1982-09-30
FR2366313A1 (fr) 1978-04-28
IE45877L (en) 1978-04-04
JPS6129960B2 (de) 1986-07-10

Similar Documents

Publication Publication Date Title
CH627901GA3 (de)
FR2366313B1 (de)
FI53419B (de)
JPS5318418U (de)
FR2349633B1 (de)
JPS52138194U (de)
JPS5295900U (de)
JPS52105435U (de)
CS176994B1 (de)
FI762093A (de)
CS178386B1 (de)
FI760918A (de)
JPS52167390U (de)
JPS5321716U (de)
CS178376B1 (de)
JPS5367265U (de)
CS177780B1 (de)
CS175506B1 (de)
JPS5385140U (de)
JPS52112898U (de)
JPS52116113U (de)
JPS52134413U (de)
CH611848A5 (de)
BG23018A1 (de)
CH600826A5 (de)

Legal Events

Date Code Title Description
ST Notification of lapse